Caffeine, a xanthine alkaloid compound, is a central nervous system stimulant that effectively drowsiness and helps regain energy and is clinically used to treat neurasthenia and coma. In recent years, […]
Obesity is a major global health issue, affecting all age groups. Obesity increases the risk of several serious human diseases, including cardiovascular disease, type 2 diabetes and cancer. Despite this […]
Parkinson’s disease is a common degenerative disease of the nervous system in the elderly, which can seriously affect the quality of life of patients and put great pressure on patients […]
Metformin has proven to be a “magic drug” beyond its application in treating diabetes. Over the past 20 years, metformin has become the mainstay of type 2 diabetes treatment and […]
The top spot in the world’s best-selling drug list may not be a suspense in the short term, according to a report by EvaluatePharma, a market research firm. In 2018, […]
Olaparib, also known as AZD-2281 or KU-59436, is a small molecule inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to […]
December 7, 2017 – Researchers from Brock University have found that certain amounts of lithium in drinking water may slow death rates in people with Alzheimer’s disease, according to a […]
December 7, 2017 – Insomnia might be an early sign of disorder for brain-associated diseases, according to the latest findings published in the neurological journal The Lancet Neurology. Researchers from […]
On Oct. 18, 2017, the Food and Drug Administration (FDA)’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has unanimously voted 16-0 to support the approval of Novo Nordisk’s semaglutide, a […]
Diabetes can be caused by multiple factors, but we still can take certain measures to lower the risks of developing diabetes. In a new research published in Diabetologia (the journal of the […]